Is any trial design description available? It’s non randomised I assume, couldn’t find anything on clinical trials.gov. Main Question is what standard of care is allowed in these c19 hospitalised patients because if discretionary and say steroids like dexa used, going to be hard to tease out what the idroxonil actually does, some potential confounders and small sample . This looks more like proof of concept trial that’ll need validation in RCT.
- Forums
- ASX - By Stock
- NOXCOVID
NOX
noxopharm limited
Add to My Watchlist
2.04%
!
5.0¢

Is any trial design description available? It’s non randomised I...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.0¢ |
Change
0.001(2.04%) |
Mkt cap ! $14.61M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 5.0¢ | $14.75K | 295K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 763 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 49807 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 763 | 0.050 |
1 | 40000 | 0.049 |
1 | 300000 | 0.048 |
2 | 114034 | 0.047 |
1 | 50000 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 49807 | 1 |
0.052 | 78600 | 1 |
0.054 | 38094 | 1 |
0.055 | 60000 | 1 |
0.056 | 20000 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online